{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-004104","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2025-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.832308+00:00","generated_at":"2026-05-27T06:50:36.436564+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Glucotrack CFO James Cardwell resigns; Peter Wulff appointed as CFO","bullets":["James Cardwell resigned as CFO effective Jan 27, 2025; will remain as consultant for transition.","Peter Wulff appointed CFO effective Jan 28, 2025; has 40+ years life sciences finance experience.","Wulff's base salary: $300k for 2025, $450k thereafter; eligible for bonuses tied to financing milestones up to $262.5k total.","Initial equity grant of options for 1.25% of outstanding common stock under 2024 Equity Incentive Plan.","Wulff most recently CFO at Biological Dynamics; previously CFO at JenaValve Technology."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-004104","json":"https://secwatch.observer/filing/0001493152-25-004104.json","markdown":"https://secwatch.observer/filing/0001493152-25-004104.md","text":"https://secwatch.observer/filing/0001493152-25-004104.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/0001493152-25-004104-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T06:50:36.436564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9627e433d3","claim":"James Cardwell resigned as Chief Financial Officer at Glucotrack, Inc..","evidence_excerpt":"On January 27, 2025, James Cardwell informed the Board of Directors (the “Board”) of Glucotrack, Inc. (the “Company”) that he was resigning as Chief Financial Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/0001493152-25-004104-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a3ae552b13","claim":"Peter C. Wulff was appointed as Chief Financial Officer at Glucotrack, Inc..","evidence_excerpt":"In connection with Mr. Cardwell’s resignation, on January 28, 2025, the Board appointed Peter C. Wulff as Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/0001493152-25-004104-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}